<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-5330-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VITAROS 3MG/GM CREAM
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALPROSTADIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/g
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Cream
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Single Dose Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        300.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GROUPE PARIMA INC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GROUPE PARIMA INC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 606]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALHAYA MEDICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ELIS PHARMACEUTICAL LTD
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G04BE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vitaros is available in two dosage strengths of 200 and 300 mcg alprostadil in 100 mg of cream. Vitaros is used to treat<br />erectile dysfunction (ED) in men 18 years of age or older. ED is the inability to attain or maintain an erection sufficient<br />for sexual intercourse. There are several causes of ED including medications that you may be taking for other<br />conditions, poor blood circulation in the penis, nerve damage, emotional problems, too much smoking or alcohol use,<br />and hormonal problems. Often ED is due to more than one cause. Treatments for ED include switching medications,<br />if you are taking a medication that causes ED, prescription medications, medical devices that produce an erection,<br />surgical procedures to correct blood flow to the penis, penile implants and psychological counseling. After application<br />of Vitaros the onset of erection is within 5 to 30 minutes. You should not stop taking any prescription medications,<br />unless told to do so by your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Vitaros<br />- If you have underlying disorders such as drop in blood pressure when going from a lying/sitting to a standing<br />position, history of a heart attack, and syncope (dizziness).<br />- If you are allergic to alprostadil or any of the other ingredients of this medicine (listed in section 6).<br />- If you have a condition that might result in a long-lasting erection or a condition such as sickle cell anaemia<br />or trait, thrombocythemia, polycythemia, multiple myeloma, or leukaemia.<br />- If you have an abnormally formed penis.<br />- If you have an inflammation or infection of the penis.<br />- If you are prone to a venous thrombosis.<br />- If you have a hyper viscosity syndrome which could result in a long-lasting erection.<br />- If you have been told not to have sex for health reasons such as heart problems or a recent stroke.<br />- If your partner is pregnant, breast feeding or of childbearing potential unless you use a condom barrier.</p><p>Warnings and precautions</p><p>Talk to your doctor or pharmacist before using Vitaros if you have a history of the following local effects that have been<br />observed with the use of Vitaros:</p><p>- prolonged erections lasting &gt;4 hours (priapism)<br />- Symptomatic hypotension (dizziness)<br />- hepatic and/or renal insufficiency, a lowered dose due to impaired metabolism may be required<br />- fainting<br />A condom should be used in the following situations:<br />- your partner is pregnant or breastfeeding<br />- your partner is of childbearing potential<br />- to prevent sexually transmitted diseases<br />- during oral sex and anal sex<br />Only latex condoms have been studied. It is not known if condom made of other materials may be damaged.</p><p>Other medicines and Vitaros</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />The use of Vitaros with other drugs used to treat Erectile Dysfunction have not been studied. Therefore, if you are<br />taking other drugs for ED, do not combine with Vitaros as there could be signs including dizziness, fainting and<br />prolonged erections.<br />Vitaros has not been tested for use with penile implants or smooth muscle relaxants such as papaverine; drugs used<br />to induce erections such as alpha blocking drugs (e.g. intracavernosal phentolamine, thymoxamine). There is a risk of<br />priapism (painful prolonged abnormal erection) when used in combination.<br />Although not studied, it is possible that Vitaros may have less of an effect when taken in combination with treatments<br />for high blood pressure, decongestants and appetite suppressants.<br />If you are taking drugs to prevent blood clots, do not take Vitaros as there may be an increased risk for bleeding or<br />blood found in the urine.<br />In combination with high blood pressure medication, Vitaros use may increase symptoms of dizziness and fainting,<br />especially in the elderly.</p><p>Pregnancy and breast-feeding and fertility<br />There are no data on the use of Vitaros in pregnant women.<br />It is not recommended to use Vitaros while breastfeeding.<br />It is not known whether Vitaros has an effect on human male fertility.<br />Driving and using machines<br />Vitaros may make you feel dizzy or faint. Do not drive or operate machinery within 1 to 2 hours after administration.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you.<br />Check with your doctor or pharmacist if you are not sure.<br />Vitaros is available in two dosage strengths of 200 and 300 mcg alprostadil in 100 mg of cream. Vitaros should be<br />used as needed to achieve an erection. Each Vitaros AccuDose&trade; container is for single use only and should be<br />properly discarded after use.<br />For an erection: the starting dose should be recommended by a physician.<br />Do not adjust your dose yourself. Talk to your doctor who will instruct you on proper technique for administration and<br />accommodation of your dose.</p><p>The onset of effect is within 5 to 30 minutes after administration.<br />The duration of effect is approximately 1 to 2 hours. But, the actual duration can vary from patient to patient.<br />Apply Vitaros to the tip of the penis within 5 to 30 minutes prior to attempting intercourse by following the<br />instructions below:</p><p>1. Wash your hands before applying Vitaros. Remove the AccuDose&trade;<br />container from the foil pouch by tearing fully down the seal from the<br />middle of the top edge. Remove the AccuDose&trade; container from the<br />sachet. Save the sachet for discarding the used AccuDose&trade; container<br />later. Remove the cap from the tip of the container.</p><p>2. Grasp the tip of the penis with one hand and gently manipulate to<br />widen the opening of the penis. Note: if you are not circumcised, first<br />retract and hold the foreskin back prior to widening the opening of the<br />penis.</p><p>3. Hold the barrel of the AccuDose&trade; container between your fingers<br />and place the tip of the container over the opening of the penis and<br />carefully push down the plunger with your thumb or finger until all the<br />cream is expelled from the AccuDose&trade; container barrel into the<br />opening and surrounding skin . Note: Do not insert the<br />tip of the AccuDose&trade; container into the opening of the penis.</p><p>4. Hold the penis in an upright position for approximately 30 seconds<br />to allow the cream to penetrate. There will likely be some cream that<br />does not fit into the opening of the penis. The amount of extra cream<br />will vary depending on the patient and it is not unusual that half of the<br />dose will remain at the edge of the opening. Do not use a second<br />AccuDose&trade; to compensate for cream not expelled into the opening<br />of the penis. Any excess cream covering the opening may be rubbed<br />gently into the opening and skin surrounding the application site with<br />the tip of a finger.</p><p>5. Remember each Vitaros dose is good for a single administration only. Replace the cap on the AccuDose&trade;<br />container and place in the opened foil sachet, fold and discard in accordance with local requirements.<br />6. Vitaros may be irritating to the eyes. Wash your hands after applying Vitaros.</p><p>Children and adolescents<br />Vitaros is not indicated for children or men below 18 years of age.<br />If you use more VITAROS than you should</p><p>Overdose with Vitaros requiring treatment has not been reported.<br />Overdose with Vitaros may result in a drop in blood pressure, fainting, dizziness, persistent pain in the penis, and<br />possible<br />prolonged erection lasting longer than 4 hours. This can result in permanent worsening of erectile function. Call your<br />doctor promptly if you suffer with any of these effects.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, VITAROS can cause side effects, although not everybody gets them.<br />If you get a long-lasting erection of more than 4 hours, contact your doctor immediately.<br />Your doctor may reduce your dose of Vitaros or discontinue your treatment.<br />Common side effects (may affect more than 1 in 10 patients):<br />You:<br />- Mild to moderate local aching, burning or pain and redness of the penis,<br />- Rash,<br />- Genital pruritus,<br />- Penile oedema<br />- Inflammation of the glans penis (balantitis)<br />- Penile tingling, throbbing numbness, burning<br />Your partner:<br />- Mild vaginal burning or itching.<br />This effect may be due to the drug or to the act of vaginal penetration. Using a water-based lubricant can help to<br />make vaginal penetration easier.<br />Uncommon but potentially serious side effects (may affect up to 1 in 100 patients):<br />You:<br />- Light - headedness/dizziness<br />- Prolonged erection for more than 4 hours<br />- Fainting<br />- Low blood pressure or rapid pulse<br />- Pain at the application site or in extremity<br />- Urethral stenosis<br />- Increase in sensitivity<br />- Penile itching<br />- Genital rash<br />- Scrotal pain<br />- Fullness in genital<br />- Lack of sensation to penis<br />- Urinary tract inflammation</p><p>Your partner:<br />- Vulvovaginal pruritus<br />*Increased sexual/physical activity in combination with Vitaros may increase the risk of heart attack or stroke in<br />patients with underlying disease/risk factors (see Section 2).</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,<br />please tell your doctor or pharmacist.</p><p>Duration of side effects:<br />Most effects are short acting and resolve within 1-2 hours</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use VITAROS after the expiry date which is stated on the carton, sachet and AccuDose&trade; container label<br />after Exp.<br />The expiry date refers to the last day of the month.<br />Store in a refrigerator (2&deg;C - 8&deg;C). Do not freeze.<br />Unopened sachets may be kept out of the refrigerator by the patient, at a temperature below 30&deg;C for up to 3 days<br />prior to use.</p><p>At the end of this period, the product should be discarded if not used.<br />Each dispenser is for single use only.<br />Once opened, use immediately, discard any unused portion.<br />Store in the original sachet in order to protect from light.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist to throw away medicines<br />you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Alprostadil<br />Each single container contains 300 micrograms of alprostadil in 100 mg of cream (3mg/g).<br />Vitaros is available in unit cartons with four (4) single dose containers and one (1) single dose container.<br />The other ingredients are purified water; ethanol, anhydrous; ethyl laurate; hydroxypropyl guar gum; dodecyl-2-N,Ndimethylaminopropionate<br />hydrochloride; potassium dihydrogen phosphate; sodium hydroxide, for pH adjustment;<br />phosphoric acid, for pH adjustment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Vitaros is a white to off-white cream supplied in AccuDose™, a single dose container. AccuDose™ is a container
consisting of a plunger, barrel, and protective cap.
Each container is provided in a protective sachet.
The sachets are composed of aluminium foil/laminate.
The container components are composed of polypropylene and polyethylene.
EFFECTS AFTER APPLICATION:
Vitaros requires between 5 to 30 minutes to begin working before you can have sexual intercourse. After administration
you can engage in foreplay, which helps arousal and the process of developing an erection. An effective dose of
Vitaros should produce an erection sufficient for sexual intercourse. The duration of the effect is approximately 1 to
2 hours. However, the actual duration will vary from patient to patient and the dose of the drug. Vitaros may not create
an erection comparable to those you experienced when you were younger. Some patients may experience some
mild pain, a burning sensation, and aching in the penis or groin area. Also, your erection may continue for a time after
orgasm or ejaculation. After your erection is over your penis may feel full, warm, and somewhat sensitive to the touch.
These effects are normal and may last for a few hours.
ADDITIONAL INFORMATION AND PRACTICAL TIPS:
You and your doctor will determine the appropriate dose of Vitaros.
If your erection cannot be maintained for the time need to have foreplay and sexual intercourse, you may need to
have your dose increased. Similarly, if an erection last longer than desired or if the side effects are not well tolerated
you may need your dose reduced. Call your doctor if you suspect that you may require an adjustment of your dose.
Factors that may enhance your erection:
- Being well rested.
- Sexual foreplay with your partner or self-stimulation while sitting or lying after application of Vitaros.
- Pelvic exercises such as tightening and releasing your pelvic and buttock muscles. These are the muscles you use
to stop urination.
- Various positions that may favour and not restrict blood flow to the penis.
Factors which may reduce your erection:
- Anxiety, fatigue, tension, and too much alcohol.
- Urination immediately after application may result in loss of medication.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Elis Pharmaceuticals.<br />Vista Business Centre<br />50 Salisbury Road<br />Hounslow<br />Middlesex TW4 6JQ<br />United Kingdom<br />Phone no.: +442036082889<br />Fax no.: +442036088979<br />Email: info@elispharmaceuticals.com<br />Manufacturer:<br />Groupe Parima Inc.<br />4450, rue Cousens<br />Saint-Laurent QC H4S 1X6<br />Canada<br />Phone no: +1.514.338.3780<br />Email: info@groupeparima.com</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa ;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC states: </strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority</em></p><p>&nbsp;</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>Council of Arab Health Ministers,</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>THIS IS A MEDICAMENT</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Medicaments is a product which affects your health and its consumption contrary to instructions is danger for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Follow strictly the doctor&rsquo;s prescription, the method of use and the Instructions of the pharmacist who sold the medicament.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>The doctor and pharmacist are the experts in medicines, their benefits and risks.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not by yourself interrupt the period of treatment prescribed for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not repeat the same prescription without consulting your doctor.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Keep all medicaments out of reach of children.</em></p></td></tr></tbody></table><p>&nbsp;</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 10/2017 Leaflet Version 01
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>فيتاروس متوفر في جرعتين بتراكيز ٢٠٠ و ٣٠٠ ميكروجرام البروستاديل في ١٠٠ ملجم من الكريم. يستخدم فيتاروس<br />لمعالجة ضعف الانتصاب عند الرجال من عمر ١٨ وما فوق. ضعف الانتصاب هو عدم القدرة على الانتصاب أو الحفاظ<br />على الانتصاب لفترة تكفي للجماع. هناك عدة أسباب لضعف الانتصاب تتضمن العلاجات التي تتناولها لعلاج<br />حالات مرضية أخرى، ضعف الدورة الدموية في القضيب، تلف الاعصاب، المشاكل العاطفية، الإفراض في التدخين أو<br />تناول الكحول أو المشاكل الهورمونية. غالباً ضعف الانتصاب عائد لأكثر من سبب. إن علاج ضعف الانتصاب<br />يتضمن تبديل للعلاجات، إذا كنت تتناول علاج يسبب خلل الانتصاب، علاجات بوصفة طبية، أجهزة ينتج عنها<br />الانتصاب، إجراءات جراحية لتصحيح تدفق الدم إلى القضيب، الغرسات (الزرعات) القضيبية والاستشارات<br />بعد وضع فيتاروس يبدأ الانتصاب خلال٥ -&nbsp;&nbsp;٣٠ دقيقة. يجب أن لا توقف أخذ أي علاجات بوصفة طبية - النفسية.<br />مالم يخبرك طبيبك بذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستخدم فيتاروس :<br />- إذا كان لديك اضطرابات كامنة مثل هبوط ضغط الدم عند التحول من وضعية الجلوس أو الاستلقاء - التهاب منطقة واسعة من الجهاز البولي.<br />إلى الوقوف، تاريخ مرضي لنوبة قلبية، إغماء (دوخة).<br />- إذا كان لديك حساسية ل (البروستاديل) أو أي من المكونات الأخرى لهذا الدواء (هذه المكونات مدرجة<br />.( في القسم ٦<br />- إذا كان لديك حالة يمكن أن ينتج عنها انتصاب طويل الأمد، أو حالة مثل فقر الدم المنجلي أو خلة منجلية،<br />كثيرة الصفيحات، كثرة خلايا الدم الحمراء، المايلوما المتعددة، أو سرطان الدم.<br />- إذا كان تكوين القضيب غير طبيعي.<br />- إذا كان عندك التهاب أو عدوى في القضيب.<br />- إذا كنت عرضة للتخثر الوريدي.<br />- إذا كان لديك أعراض لزوجة مفرطة والتي يمكن أن ينتج عنها انتصاب طويل المدى.<br />- إذا تم إخبارك بعد ممارسة الجنس لأسباب صحية مثل مشاكل قلبية أو سكتة دماغية من وقت قريب.<br />- إذا كانت شريكتك في العملية الجنسية حامل، أو ترضع من صدرها، أو احتمال وجود حمل لديها<br />مالم يستخدم عازل منع الحمل.</p><p dir="RTL"><br />تحذيرات واحتياطات :</p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل استخدام فيتاروس إذا كان لديك تاريخ من الآثار الموضعية التالية والتي تمت<br />ملاحظتها مع استعمال فيتاروس<br />- انتصاب مطول يدوم أكثر من ٤ ساعات (انتصاب القضيب المستمر).<br />- أعراض انخفاض ضغط الدم (الدوخة).<br />- القصور الكبدي أو الكلوي - قد يلزم استعمال جرعة مخفضة بسبب ضعف التمثيل الغذائي.<br />- الإغماء<br />يجب استخدام عازل منع الحمل في الحالات التالية:<br />- شريكتك في العملية الجنسية حامل أو ترضع من صدرها.<br />- احتمال أن شريكتك حامل.<br />- لمنع انتقال الأمراض الجنسية.<br />- أثناء الجنس الفموي والجنس في الشرج.<br />تمت دراسة العازل المصنوع من اللاتكس فقط. ومن غير المعلوم إذا كان العازل المصنوع من مواد أخرى يمكن أن يتضرر.</p><p dir="RTL">الأدوية الأخرى وفيتاروس :</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تناولت أو تتناول مؤخراً أو يمكن أن تتناول أدوية أخرى. إن استخدام فيتاروس مع أدوية<br />أخرى تستخدم لمعالجة ضعف الانتصاب لم يتم دراستها، ولذلك إذا كنت تتناول أي أدوية أخرى من أجل ضعف<br />الانتصاب، لا تجمع بينها وبين فيتاروس، لأنه يمكن أن تكون هناك علامات تتضمن الدوخة، الإغماء والانتصاب المطول.<br />لم يتم اختبار فيتاروس للاستخدام مع غرسات (زرعات) في القضيب أو مرخيات العضلة الملساء داخل التجويف<br />الكهفي مثل دواء (بابافيرين). الأدوية التي تستخدم لتحفيز الانتصاب مثل مثبطات الفا (مثال: اننتراكا فيرنوسال<br />فينوتولامين، ثيموكسامين) يكون هناك خطر الانتصاب المستمر (انتصاب غير طبيعي طويل مؤلم) عندما يستخدم<br />بالتزامن مع بعض.<br />رغم أنه لم يدرس، فإنه من الممكن لفيتاروس أن يكون أقل أثر عندما يؤخذ بالتزامن مع علاجات لضغط الدم المرتفع،<br />مزيلات الاحتقان وأدوية تقليل الشهية.<br />إذا كنت تتناول عقار لمنع تجلط الدم، لا تستخدم فيتاروس وإلا يمكن أن يكون هناك خطر متزايد للنزف أو وجود دم<br />في البول. إن استعمال فيتاروس بالتزامن مع أدوية ضغط الدم المرتفع ممكن أن يزيد أعراض الدوخة والإغماء،<br />وخصوصاً عند الكبار.</p><p dir="RTL"><br />الحمل والإرضاع من الثدي والخصوبة</p><p dir="RTL">لا يوجد بيانات عن استخدام فيتاروس في النساء الحوامل.<br />لا ينصح باستخدام فيتاروس أثناء الإرضاع من الثدي.<br />إنه من غير المعلوم فيما إذا كان هناك تأثير ل فيتاروس على خصوبة الذكر.</p><p dir="RTL">قيادة السيارات واستخدام الآلات :<br />يمكن أن يجعلك فيتاروس تشعر بالدوخة أو الإغماء. لا تقود السيارة ولا تشغل الآلات من ساعة إلى ساعتين بعد<br />تعاطي الدواء.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائماً استخدم هذا الدواء كما أخبرك طبيبك، وإذا لم تكن متأكداً راجع طبيبك أو الصيدلي. إن دواء فيتاروس متوفر<br />بتركيزين ٢٠٠ و ٣٠٠ ميكروجرام من مادة (البروستاديل) في ١٠٠ ملجم من الكريم. يجب أن تستخدم فيتاروس حسب<br />الحاجة ليؤدي للانتصاب. كل حاوية (انبوبة) من جرعة فيتاروس هي للاستخدام مرة واحدة فقط ويجب التخلص<br />منها بشكل مناسب بعد الاستخدام.<br />من أجل الانتصاب: الجرعة الأولية يجب أن يوصى بها من قبل الطبيب.<br />لا تعدل الجرعة بنفسك، تحدث إلى طبيبك الذي سوف يرشدك إلى الأسلوب المناسب للاستخدام وملاءمة الجرعة.<br />لا تستعمل فيتاروس أكثر من٢-&nbsp; ٣ مرات في الأسبوع، ومرة واحدة فقط في خلال ٢٤ ساعة.<br />بداية التأثير تكون في خلال ٥- ٣٠ دقيقة بعد وضع الدواء. وفترة التأثير تكون تقريباً من ١ -٢ ساعة<br />لكن الفترة الفعلية يمكن أن تختلف من مريض لآخر.<br />ضع فيتاروس على فتحة القضيب (مجرى البول) قبل&nbsp;٥- ٣٠ دقيقة من محاولة الاتصال الجنسي -<br />باتباع التعليمات المذكورة أدناه:</p><p><br />1 اغسل يديك قبل استعمال فيتاروس. أخرج الوعاء الذي<br />يحوي الجرعة من جراب الرقاقة المعدنية بتمزيق الحافة<br />المحززة كاملاً. أخرج الوعاء الذي يحوي الجرعة من<br />الكيس الصغير، واحتفظ بالكيس الصغير للتخلص<br />من العبوة المستعملة لاحقاً. انزع الغطاء من رأس<br />الوعاء&nbsp;<br />2 امسك النهاية المستدقة للقضيب بيد واحدة وبلطف<br />اعمل على توسيع فتحة القضيب.<br />ملاحظة: إذا لم تكن مختونا ً ، أولا ً اسحب وامسك<br />قلفة القضيب إلى الخلف قبل أن توسع فتحة<br />القضيب&nbsp;<br />3 امسك اسطوانة وعاء الجرعة بين أصابعك وضع نهاية<br />الوعاء فوق فتحة القضيب وبعناية ادفع للأسفل<br />المكبس بإبهامك أو بإصبعك حتى يتم إخراج كل<br />الكريم من ماسورة وعاء الجرعة في فتحة القضيب<br />&nbsp;والجلد المحيط بها&nbsp;</p><p>ملاحظة: لا تدخل قمة وعاء الجرعة في فتحة القضيب.<br />&nbsp;</p><p>4 امسك القضيب في وضع منتصب للأعلى تقريباً لمدة ٣٠ ثانية لتسمح للكريم بالتغلغل داخله. من المرجح أن يكون<br />هناك جزء من الكريم لم يدخل في فتحة القضيب. الكمية الزائدة من الكريم سوف تختلف من مريض لآخر، وذلك<br />يعتمد على المريض، ليس غير عادي أن تبقى نصف الجرعة على حافة القضيب (رأس القضيب). لا تستعمل جرعة<br />ثانية لتعوض عن الكريم الذي لم يدخل داخل فتحة القضيب. أي زيادة من الكريم الذي تغطي فتحة القضيب، يمكن<br />أن تدلك برفق على فتحة القضيب والجلد المحيط بمكان وضع الكريم برأس الإصبع.<br />5 تذكر بأن كل جرعة من فيتاروس هي للاستخدام مرة واحدة فقط. أعد العطاء على وعاء الجرعة ثم ضعه في كيس<br />الرقاقة المعدنية المفتوحة، ثم اطويه وارميه (تخلص منه) طبقاً لما يستلزمه الحال في بلدك.<br />6 يمكن أن يسبب فيتاروس تهيج للعيون. اغسل يدك بعد وضع الدواء.</p><p>&nbsp;</p><p>الأطفال والبالغون :<br />إن فيتاروس لا يوصف للأطفال أو الذكور تحت عمر ١٨ سنة.<br />إذا استعملت جرعة من فيتاروس أكثر مما يجب :<br />لم تسجل استعمال جرعة زائدة من فيتاروس تستلزم المعالجة، إن استعمال جرعة زائدة من فيتاروس يمكن أن ينتج<br />عنها هبوط في ضغط الدم، إغماء، دوخة، ألم مستمر في القضيب، واحتمال حدوث انتصاب للقضيب يدوم أكثر من<br />٤ ساعات.<br />وهذا يمكن أن ينتج عنه تفاقم حالة خلل الانتصاب. اتصل بطبيبك إذا كنت تعاني من أي من هذه الآثار.<br />إذا كان لديك أسئلة إضافية حول استعمال هذه الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كل الأدوية، فإن فيتاروس يمكن أن يسبب آثار جانبية، ولا تحدث هذه الآثار مع كل المرضى. إذا حدث عندك انتصاب<br />استمر فترة طويلة (أكثر من ٤ ساعات) اتصل بطبيبك في الحال، فإن طبيبك يمكن أن يخفض الجرعة أو يوقف علاجك.<br />آثار جانبية شائعة (يمكن أن تؤثر بأكثر من ١ من ١٠ مرضى):<br />أنت:<br />- وجع موضعي خفيف إلى متوسط، حرقة أو ألم واحمرار في القضيب.<br />- طفح جلدي.<br />- حكة بالمناطق التناسلية.<br />- وذمة القضيب.<br />- التهاب حشفة القضيب.<br />- وخز بالقضيب، خدر وتنميل، حرقة.</p><p>شريكتك في العملية الجنسية:<br />- حرقة مهبلية خفيفة أو حكة،<br />هذا الأثر يمكن أن يكون بسبب الدواء أو بفعل الاختراق المهبلي. إن استخدام مزلق ذات أساس مائي يمكن أن يجعل<br />الاختراق المهبلي أسهل.<br />غير شائعة، لكن آثار جانبية خطيرة محتملة (يمكن أن تؤثر لغاية ١ من ١٠٠ مريض)<br />أنت:<br />- خفة في الرأس / دوخة.<br />- انتصاب طويل أكثر من ٤ ساعات.<br />- إغماء.<br />- انخفاض ضغط الدم أو نبض سريع.<br />- ألم مكان وضع الدواء أو في الأطراف.<br />- تضيق الاحليل.<br />- زيادة في الحساسية.</p><p>- حكة قضيبية.<br />- طفح جلدي تناسلي.<br />- ألم بمنطقة الصفن.<br />- التهاب المسالك البولية.<br />- نقص الاحساس في القضيب.</p><p>شريكتك<br />- حكة فرجية مهبلية.<br />* ازدياد النشاط الجنسي، بالاشتراك مع فيتاروس يمكن أن يزيد خطر نوبة قلبية أو السكتة في المرضى الذين لديهم<br />.( المرض كامن / عوامل الخطر (انظر القسم ٢<br />إذا أحسست بأي من الآثار الجانبية الخطيرة، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة، يرجى إخبار<br />طبيبك أو الصيدلي.</p><p>مدة الآثار الجانبية:<br />معظم الآثار تعمل لفترة قصيرة ثم تزول بعد 1-2&nbsp;ساعة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول أيدي ونظر الأطفال .<br />لا تستخدم فيتاروس بعد انتهاء تاريخ الصلاحية المذكور على العلبة، وعلى الكيس الصغير، وعلى رقعة وعاء الجرعة.<br />يشير تاريخ الصلاحية إلى آخر يوم من الشهر.<br />يحفظ في الثلاجة (البراد) بين درجة حرارة ( 2-8&nbsp;درجة مئوية)، لا تدعه يتجمد.<br />يمكن أن يحفظ المريض أكياس الدواء غير المفتوحة بدرجة حرارة دون ٣٠ درجة مئوية لمدة ٣ أيام قبل الاستعمال.<br />بعد هذه الفترة يجب أن يتم التخلص من المنتج إذا لم يستعمل.<br />كل عبوة هي لاستعمال واحد فقط.<br />عند فتح العلبة استعملها في الحال، وتخلص من الجزء غير المستعمل.<br />يحفظ في العبوة الأصلية للحماية من الضوء.<br />لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية.<br />اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي (البروستاديل)<br />كل وعاء جرعة يحتوي على ٣٠٠ ميكروجرام من (البروستاديل) في ١٠٠ ملجم من الكريم ( ٣ ملجم / جم).<br />فيتاروس متوفر في وحدات كرتون من ( ٤) حاويات جرعة مفردة.<br />المكونات الأخرى هي ماء منقى، ايثانول أنهيدروس (سكر لامائي)، إثيل لوريت، هيدروكسيبروبيل صمغ الجوار،<br />دوديكيل - ٢-ن-ن-دايميثيل امينوبروبيونات هيدروكلورايد، بوتاسيوم دايهيدروجين فوسفات، صوديوم هيدروكسيد<br />.ph حمض الفوسفوريك لتعديل الأس الهيدروجيني ،ph لتعديل الأس الهيدروجيني</p><p>كيف يبدو فيتاروس وماهي محتويات العبوة :</p><p>فيتاروس هو كريم أبيض إلى أبيض ذات صفرة خفيفة معبأ بإناء من جرعة واحدة يتكون وعاء الجرعة من مكبس،<br />وماسورة وغطاء واقي. وكل وعاء معد في كيس واقي. الأكياس مصنوعة من رقائق الألمنيوم. أما مكونات وعاء الجرعة<br />فهي بوليبروبيلين وبوليثيلين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>آثار الدواء بعد وضعه</p><p>يتطلب فيتاروس ما بين ٥ - ٣٠ دقيقة ليبدأ العمل قبل أن تتمكن من القيام بالاتصال الجنسي. بعد وضع الدواء&nbsp;<br />تستطيع أن تبدأ المداعبة، الأمر الذي يساعد على تنبيه وتطوير عملية الانتصاب. إن الجرعة الفعالة من فيتاروس يجب<br />أن تؤدي إلى انتصاب يكفي للاتصال الجنسي. مدة التأثير تقريباً من ١ -٢ ساعة. مع ذلك فإن الفترة الحقيقة سوف&nbsp;<br />تختلف من مريض لآخر وجرعة الدواء. ممكن أن لا يحدث فيتاروس انتصاب بالمقارنة مع ذلك الذي عرفته عندما كنت<br />شاباً. بعض المرضى ممكن أن يشعروا بألم خفيف في منطقة العانة، إحساس بالحرقة، وجع في القضيب أو ما بين<br />الفخذين. كذلك من الممكن أن يستمر الانتصاب بعض الوقت بعد هزة الجماع أو القذف. بعد أن ينتهي الانتصاب يمكن<br />أن تشعر بامتلاء في القضيب، دفء، ونوعاً ما حساسية من اللمس. هذه الآثار طبيعية ويمكن أن تدوم بضع ساعات.</p><p>&nbsp;</p><p>معلومات إضافية وأفكار عملية مفيدة :<br />أنت وطبيبك سوف تقرران الجرعة الملائمة من فيتاروس. فإذا كان لا يمكن المحافظة على الانتصاب عندك لوقت كا ٍ ف<br />للقيام بالاتصال الجنسي ومقدماته، فيمكن أن تحتاج لزيادة الجرعة، وبالمثل إذا كان الانتصاب يدوم فترة أطول من<br />المرغوب، أو أن الآثار الجانبية لا تحتمل، فإنه يلزمك تخفيض الجرعة. اتصل بطبيبك إذا كنت تشك بأن وضعك يتطلب<br />تعديل الجرعة.</p><p>عوامل يمكن أن تقوي الانتصاب<br />- أن تكون مرتاحاً بشكل جيد.<br />- مقدمات الاتصال الجنسي مع شريكتك، الإثارة الذاتية بينما أنت جالس أو مستلقي بعد وضع فيتاروس.<br />- تمارين الحوض مثل شد ورخي عضلات الحوض والردفين. هذه هي العضلات التي تستخدمها لتوقف التبول.<br />- أوضاع مختلفة يمكن أن تكون مفضلة ولا تحد من تدفق الدم إلى القضيب.</p><p>عوامل يمكن أن تقلل الانتصاب<br />- القلق، الإعياء، التوتر، والإفراط في الكحول.<br />- التبول مباشرة بعد وضع الدواء، يمكن أن ينتج عنه فقدان العلاج.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك رخصة التسويق :</p><p>إليس فارماسيوتيكالز<br />مركز فيستا للأعمال (فيستا بزنس سنتر)<br />٥٠ طريق سالزبوري<br />هونسلو<br />ميدلسكس&nbsp;TW4 6JQ<br />المملكة المتحدة<br />هاتف:&nbsp;+٤٤٢٠٣٦٠٨٢٨٨٩<br />فاكس:&nbsp;+٤٤٢٠٣٦٠٨٨٩٧٩</p><p>البريد الإلكتروني:&nbsp;info@elispharmaceuticals.com</p><p>&nbsp;</p><p>المصنعون :<br />مجموعة باريما آي إن سي.<br />٤٤٥٠ ، شارع كوسينس<br />سان لوران&nbsp;QC H4S1X6</p><p>كندا<br />هاتف: 3780-338-514-1+</p><p>البريد الإلكتروني:&nbsp;info@groupeparima.com</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>المملكة العربية السعودية:</em></strong></p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--></p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>&nbsp;</p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز االتصال الموحد: 19999</p><p dir="RTL">البريد الإلكتروني npc.drug@sfda.gov.sa :</p><p dir="RTL">الموقع الإلكتروني https://ade.sfda.gov.sa :</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1026" type="#_x0000_t75" style='width:411.6pt;
 height:71.8pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>دول الخليج العربي الأخرى:</em></strong></p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--></p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالجهات الوطنية في كل دولة</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:324.9pt;
 height:16.5pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">مجلس وزراء صحة العرب:</p><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>إن هذا الدواء</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدواء مستحضر يؤثر على صحتك واستهلاكه خلافا للتعليمات يعرضك للخطر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلي الذي صرفها لك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطبيب والصيدلي هما الخبيران في الدواء، وفي نفعه وضرره.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تكرر صرف الدواء بدون استشارة الطبيب المختص.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تترك الأدوية في متناول الأطفال.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">اتحاد الصيادلة العرب</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ ١٠ /٢٠١٧ ، الإصدار ٠١ 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vitaros 3 mg/g cream

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each single use container contains 300 micrograms of alprostadil in 100 mg of cream (3
mg/g).
For a full list of excipients see Section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cream
Vitaros is a white to off-white cream supplied in AccuDose, a single dose container.
AccuDose is a container consisting of a plunger, barrel, and protective cap provided in a
protective sachet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of men &ge; 18 years of age with erectile dysfunction, which is the inability to<br />achieve or maintain a penile erection sufficient for satisfactory sexual performance</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vitaros is applied to the tip of the penis.<br />Vitaros is available in two dosage strengths of 200 and 300 mcg alprostadil in 100 mg of<br />cream. Vitaros should be used as needed to achieve an erection. Each Vitaros AccuDose<br />container is for single use only and should be properly discarded after use. The onset of<br />effect is within 5 to 30 minutes after administration. The duration of effect is<br />approximately 1 to 2 hours. However, the actual duration will vary from patient to<br />patient. Each patient should be instructed by a medical professional on proper technique<br />for administration of Vitaros prior to self-administration. The maximum frequency of use<br />no more than 2-3 times per week and only once per 24-hour period.<br />The initial dose should be recommended by a physician. A starting dose with the 300 mcg<br />dose can be considered especially in patients with serious ED, co-morbidity or failure to<br />PDE-5 inhibitors. Those patients that do not tolerate the 300 mcg dose due to local side<br />effects can be titrated to the lower 200 mcg dose.<br />Patients should be given instruction on proper administration technique, information on<br />possible side effects (e.g., dizziness, fainting) and the need to avoid operating machinery<br />until one is aware of their tolerance to the drug. In the clinical trial there was a higher<br />withdrawal rate in the 300 mcg treated group compared to the 200 mcg group, 30%<br />compared to 20% respectively.<br />Method of administration:<br />Apply Vitaros to the tip of the penis (meatus) within 5 to 30 minutes prior to attempting<br />intercourse by following the instructions below:<br />1) Wash your hands before applying Vitaros. Remove the AccuDose container from the<br />sachet by tearing fully down the seal from the middle of the top edge. Remove the<br />AccuDose container from the sachet. Save the sachet for discarding the used AccuDose<br />container later. Remove the cap from the tip of the AccuDose container. See Fig. 1.<br />2) Grasp the tip of the penis with one hand and gently manipulate to widen the opening of<br />the penis. See Fig. 2 (Note, if you are not circumcised, first retract and hold the foreskin<br />back prior to widening the opening of the penis).<br />3) Hold the barrel of the AccuDose container between your fingers and place the tip of<br />the container over the opening of the penis and carefully push down the plunger with your<br />thumb or finger until all the cream is expelled from the AccuDose container barrel into<br />the opening and surrounding skin. (Figure 3). Note: Do not insert the tip of the<br />AccuDose container into the opening of the penis.<br />4) Hold the penis in an upright position for approximately 30 seconds in order to allow<br />the cream to penetrate. There will likely be some cream that does not fit into the opening<br />of the penis. The amount of extra cream will vary depending on the patient and it is not<br />unusual that half of the dose will remain at the edge of the opening. Do not use a second<br />AccuDose to compensate for cream not expelled into the opening of the penis. Any<br />excess cream covering the opening may be rubbed gently into the opening and skin<br />surrounding the application site with the tip of a finger.<br />5) Remember, each Vitaros dose is good for a single administration only. Replace the cap<br />on the AccuDose container and place in the opened sachet, fold and discard in<br />accordance with local requirements.<br />6) Vitaros may be irritating to the eyes. W ash your hands after applying Vitaros.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vitaros should not be used in patient with any of the following
- Underlying disorders such as orthostatic hypotension, myocardial infraction and
syncope.
- Known hypersensitivity to alprostadil or any of the ingredients in Vitaros.
- Conditions that might predispose them to priapism, such as sickle cell anaemia or
trait, thrombocythemia, polycythemia or multiple myeloma or, leukaemia.
- Abnormal penile anatomy such as severe hypospadias, in patients with anatomical
deformation of the penis, such as curvature, and in patients with urethritis and
balanitis (inflammation/infection of the glans of the penis).
- Prone to venous thrombosis or who have a hyperviscocity syndrome and are
therefore at increased risk of priapism (rigid erection lasting 4 or more hours).
- Vitaros should not be used in patients for whom sexual activity is inadvisable as
in men with unstable cardiovascular or unstable cerebrovascular conditions.
- Vitaros should not be used for sexual intercourse with a woman with childbearing
potential unless the couple uses a condom barrier.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Local effects: prolonged erections lasting &gt; 4 hours (priapism), although rare, were<br />observed with the use of Vitaros. Priapism was observed in the two 3-month studies in 1<br />patient (0.06%) and in the &gt; 6-month study in 5 (0.4%) patients, including 4 (0.3%) in the<br />200 mcg and 1 (0.1%) in the 300 mcg groups. If priapism occurs, the patient should seek<br />immediate medical assistance. If priapism is not treated immediately, penile tissue<br />damage and permanent loss of potency may result.<br />Symptomatic hypotension (dizziness) and syncope occurred in a small percent of<br />patients (2/459 (0.4%), 6/1591 (0.4%), and 6/1280 (0.5%) at the 100, 200 and 300 mcg<br />alprostadil doses, respectively, during dosing in the Phase 3 studies. Patients should be<br />cautioned to avoid activities, such as driving or hazardous tasks, where injury could result<br />if hypotension or syncope occurs after Vitaros administration.<br />Before initiation of treatment with Vitaros, causes of erectile dysfunction, that are<br />treatable, should be excluded by appropriate diagnostic methods.<br />In addition, patients with underlying disorders, such as orthostatic hypotension, myocardial<br />infarction and syncope, should not use Vitaros (see CONTRAINDICATIONS, section 4.3).<br />Clinical studies have not been conducted in patients with a history of neurological disease<br />or spinal injury.<br />The pharmacokinetics of Vitaros have not been formally studied in patients with hepatic<br />and /or renal insufficiency. The dose may need to be lowered in these populations due to<br />impaired metabolism.<br />General Precautions:<br />Vitaros should be applied according to the instructions above. Inadvertent intraurethral<br />exposure may result in penile burning or tingling sensation and pain. Repeated longer<br />term intraurethral exposure of Vitaros is unknown.<br />Patients should be informed that Vitaros offers no protection from the transmission of<br />sexually transmitted diseases. Patients and partners who use Vitaros need to be counselled<br />about the protective measures that are necessary to guard against the spread of sexually<br />transmitted agents, including the human immunodeficiency virus (HIV).<br />Health care professionals should encourage their patients to inform their sexual partners<br />that they are using Vitaros. Partners of Vitaros users can experience adverse events, most<br />commonly vaginal irritation. A condom barrier is therefore recommended.<br />The effects of Vitaros on the oral or anal mucosa has not been studied. A condom barrier<br />should be used for oral sex (fellatio) or anal sex.<br />Vitaros has no contraceptive properties. It is recommended that couples using Vitaros use<br />adequate contraception if the female partner is of childbearing potential<br />There is no information on the effects on early pregnancy of alprostadil at the levels<br />received by the female partners. A condom barrier should be used for sexual intercourse<br />with women of childbearing age, pregnant or lactating women.<br />Only latex material based condoms have been investigated together with its use and other<br />materials may not exclude possible risk for occurrence of damage to the condom.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacokinetic or pharmacodynamic interaction studies with Vitaros were not done.<br />Based on the nature of metabolism (see &ldquo;Pharmacokinetics&rdquo;) drug-drug interactions are<br />considered unlikely.<br />Effect of Interaction<br />The safety and efficacy for Vitaros in combination with other treatments for erectile<br />dysfunction, especially for the treatment with Phosphodiesterase-5 inhibitors (PDE-5) or<br />sildenafil, tadalafil and vardenafil, has not been studied. Therefore, Vitaros should not be<br />used in combination with PDE5 inhibitors. As both Vitaros and PDE5 inhibitors have<br />cardiovascular effects, an additive increased cardiovascular risk cannot be excluded.<br />No interaction studies have been performed for Vitaros in combination with penile<br />implants or smooth muscle relaxants such as papaverine; drugs used to induce erections<br />such as alpha blocking drugs (e.g. intracavernosal phentolamine, thymoxamine). There is<br />a risk of priapism (painful prolonged abnormal erection) when used in combination.<br />No interaction studies have been performed for Vitaros in combination with<br />sympathomimetics, decongestants and appetite suppressants. When used in combination<br />there may be a reduced effect of alprostadil (drug interaction inhibition).<br />No interaction studies have been performed for Vitaros in combination with<br />anticoagulants and platelet aggregation inhibitors. When used in combination there may<br />be an increased risk of urethral bleeding, haematuria.<br />Patients concomitantly treated with antihypertensive drugs and vasoactive medications<br />may show an increased risk for hypotension, especially in elderly patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are no data on the use of Vitaros in pregnant women. The indirect exposure to<br />alprostadil in women is likely to be low.<br />Animal data on higher doses of alprostadil show reproductive toxicity (see section 5.3).<br />Pregnant women should not be exposed to Vitaros.<br />Breast-feeding<br />It is not known if indirect exposure to alprostadil via Vitaros will lead to significant<br />excretion in breast milk. It is not recommended to use Vitaros while breastfeeding.<br />Fertility<br />In male rabbits, atrophy of the seminiferous tubules of the testes was observed after<br />repeated dosing. It is not known whether Vitaros has an effect on human male fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects of the ability to drive and use machines have been performed.<br />As dizziness and syncope (fainting) have been reported rarely in clinical trials with<br />Vitaros, patients should avoid activities, such as driving or hazardous tasks, where injury<br />could result if syncope occurs within 1 to 2 hours after administration of Vitaros.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tabulated list of adverse reactions<br />The most frequently reported adverse events in treatment with Vitaros are presented in<br />the table below. (Very common &ge; 1/10; Common &ge; 1/100, &lt;1/10; Uncommon &ge;1/1000,<br />&lt;1/100; Rare &ge;1/10000, &lt;1/1000; Very rare &lt;1/10000)<br />Priapism (an erection lasting longer than 4 hours) is a serious condition that requires<br />prompt treatment by a physician.<br />Table 1 Adverse Reactions<br />System Organ Class Frequency Adverse Reaction<br />(MedDRA)<br />Nervous System Uncommon Hyperesthesia<br />Disorders<br />Vascular Systems Uncommon Dizziness Syncope Hypotension<br />Disorders*<br />Skin and subcutaneous Common Rash<br />tissue disorders<br />Musculoskeletal and Uncommon Pain in Extremity<br />Connective tissue<br />Disorders<br />Renal Disorder Common Urethral pain<br />Urinary disorder Uncommon Urethral stenosis<br />Urinary Tract Inflammation<br />Reproductive system Common Penile Burning<br />and breast disorders Penile Pain<br />Penile Erythema<br />Genital Pain<br />Penile Erythema<br />Genital Discomfort<br />Genital Erythema<br />Erection Increased<br />Pruritis Genital<br />Penile Oedema<br />Balantitis<br />Penile Tingling<br />Penile throbbing<br />Penile numbness<br />In women partners:<br />Vulvovaginal Burning Sensation<br />Vaginitis<br />Uncommon Penile Itching<br />Genital Rash<br />Scrotal Pain<br />Fullness genital<br />Excessive rigidity<br />Lack of sensation to Penis<br />Prolonged erection/priapism<br />In women partners:<br />Vulvovaginal Pruritis<br />General Disorders and Uncommon Application Site Pain<br />Administration<br />Site Conditions<br />Special populations<br />*There is no clear indication that alprostadil increases the risk of cardiovascular events,<br />other than the vasodilative effects, but it cannot be excluded that patients with underlying<br />disease/risk factors are at increased risk in combination with increased sexual/physical<br />activity that is associated with alprostadil use (see 4.3 and 4.4)<br />To report any side effects: Saudi Arabia<br />National Pharmacovigilance and Drug Safety Center (NPC)<br />Fax: +966-11-205-7662<br />To call the executive management of vigilance and crisis management:<br />+966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340<br />Toll-free: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Over dosage requiring treatment has not been reported with Vitaros. Over dosage with<br />Vitaros may result in hypotension, syncope, dizziness, penile pain and possible priapism<br />(rigid erection lasting &gt; 4 hours). Priapism can result in permanent worsening of erectile<br />function. Patients suspected of overdose who develop these symptoms should be under<br />medical supervision until systemic or local symptoms have been resolved.<br />Should a prolonged erection lasting 4 or more hours occur, the patient should be advised<br />to seek medical help. The following actions can be taken:<br />&bull; The patient should be supine or lying on his side. Apply an ice pack alternately<br />for two minutes to each upper inner thigh (this may cause a reflex opening of the<br /> venous valves). If there is no response after 10 minutes, discontinue treatment.<br />If this treatment is ineffective and a rigid erection has lasted for more than 6 hours,<br />penile aspiration should be performed. Using aseptic technique, insert a 19-21 gauge<br />butterfly needle into the corpus cavernosum and aspirate 20-50 ml of blood.<br />This may detumesce the penis. If necessary, the procedure may be repeated on<br />the opposite side of the penis.<br />&bull; If still unsuccessful, intracavernous injection of &alpha;-adrenergic medication is<br />recommended. Although the usual contraindication to intrapenile administration<br />of a vasoconstrictor does not apply in the treatment of priapism, caution is<br />advised when this option is exercised. Blood pressure and pulse should be<br />continuously monitored during the procedure. Extreme caution is required in<br />patients with coronary heart disease, uncontrolled hypertension, cerebral<br />ischaemia, and in subjects taking monoamine oxidase inhibitors. In the latter<br /> case, facilities should be available to manage a hypertensive crisis.<br />&bull; A 200 microgram/ml solution of phenylephrine should be prepared, and 0.5 to 1.0 ml<br />of the solution injected every 5-10 minutes. Alternatively, a 20 microgram/ml<br />solution of adrenaline should be used. If necessary, this may be followed by further<br />aspiration of blood through the same butterfly needle. The maximum dose of<br /> phenylephrine should be 1 mg, or adrenaline 100 micrograms (5ml of the solution).<br />&bull; As an alternative metaraminol may be used, but it should be noted that fatal<br />hypertensive crises have been reported. If this still fails to resolve the priapism,<br />the patient should immediately be referred for surgical management.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic Group: Drugs used in erectile dysfunction<br />ATC Code: G04BE01<br />Mechanism of Action:<br />Alprostadil is chemically identical to prostaglandin E1, the actions of which include<br />vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and<br />increase in cavernosal artery blood flow, causing penile rigidity.<br />After application of Vitaros the onset of erection is within 5 to 30 minutes. Alprostadil<br />has a short half-life in man and improvement of erections may last from 1 to 2 hours after<br />dosing.<br />Efficacy: Two Pivotal Phase 3 studies evaluated the efficacy of Vitaros in patients with<br />Erectile Dysfunction. Relative to placebo, a statistically significant overall improvement<br />was observed in the 100, 200 and 300 mcg alprostadil treatment groups in each of the<br />primary efficacy endpoints; i.e., the erectile function (EF) domain of the IIEF<br />(International Index of Erectile Function) score and increased success in vaginal<br />penetration and ejaculation. Additionally, there were also overall improvements and<br />statistical significance of the treatment groups compared to placebo in several of the<br />secondary efficacy variables, including the other IIEF domain scores (orgasmic function,<br />intercourse satisfaction, and overall satisfaction), Patient Self-Assessment of Erection<br />(PSAE), and Global Assessment Questionnaire (GAQ).<br />Subpopulation Efficacy: Similar improvements to those of all patients were generally<br />observed within the subpopulations (diabetic, cardiac, prostatectomy, hypertensive<br />patients, and patients who failed previous therapy with Viagra) and two age groups (&lt; 65<br />and &gt; 65 years) in the IIEF EF domain scores.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption: Absolute bioavailability by the topical route was not determined. In a<br />pharmacokinetic study, patients with erectile dysfunction were treated with 100 mg of<br />Vitaros Cream at doses of 100, 200 and 300 mcg of alprostadil. Plasma levels of PGE1,<br />and its metabolite, PGE0 were low or undetectable in most subjects at most of the postdose<br />blood sampling times and pharmacokinetic parameters could not be estimated.<br />Cmax values and AUC values of 15-keto-PGE0 were low and showed a less than dose<br />proportional increase over the 100 &ndash; 300 mcg dose range. The maximum plasma<br />concentrations of 15-keto-PGE0 were achieved within one hour after administration.<br />Table 2: Mean (SD) Pharmacokinetic Parameters f or 15-keto-PGE0<br />Placebo Vitaros 100 Vitaros 200 mcg Vitaros 300<br />Parameter (N=5) mcg (N=5) (N=5) mcg (N=5)<br />AUC<br />a<br />388 (256) 439 (107) 504 (247) 960 (544)<br />(pg*hr/mL)<br />Cmax (pg/mL) 23 (19) 202 (229) 120 (103) 332 (224)<br />Tmax (hr) 6 (8) 0.6 (0.4) 1 (0.7) 0.7 (0.3)<br />T1/2 (hr) 4 (--)<br />b<br />5 (3) 3 (1)<br />c<br />6 (6)<br />a<br />AUC is the area under the plasma concentration curve from time zero to hour<br />24<br />b<br />Only 1 subject had sufficient data for estimation of half-life.<br />c<br />Only 3<br />subjects had sufficient data for estimation of half-life.<br />SD = standard deviation<br />Distribution: After alprostadil administration to the meatus and glans of the penis,<br />alprostadil is rapidly absorbed into the corpus spongiosum and corpora cavernosa through<br />collateral vessels. The remainder passes into the pelvic venous circulation through veins<br />draining the corpus spongiosum.<br />Metabolism: Following topical administration, PGE1 is rapidly metabolized locally by<br />enzymatic oxidation of the 15-hydroxyl group to 15-keto-PGE1. 15keto-PGE1 retains<br />only 1-2% of the biological activity of PGE1 and is rapidly reduced to form the most<br />abundant inactive metabolite, 13, 14-dihydro, 15keto-PGE which is cleared primarily by<br />the kidney and liver.<br />Excretion: After intravenous administration of tritium-labelled alprostadil in man,<br />labelled drug disappears rapidly from the blood in the first 10 minutes and only low-level<br />radioactivity remains in the blood after 1 hour. The metabolites of alprostadil are excreted<br />primarily by the kidney with approximately 90% of the administered intravenous dose<br />excreted in the urine within 24 hours after administration. The remainder is excreted in<br />the faeces. There is no evidence of tissue retention of alprostadil or its metabolites<br />following intravenous administration.<br />Pharmacokinetics in Special Populations:<br />Pulmonary Disease: Patients with pulmonary disease may have a reduced capacity to<br />clear the drug. In patients with adult respiratory distress syndrome, pulmonary extraction<br />of intravenously administered PGE1 was reduced by approximately 15% compared to a<br />control group of patients with normal respiratory function.<br />Gender: The effects of gender on the pharmacokinetics of the Vitaros have not been<br />studied and pharmacokinetic studies have not been conducted in female partners.<br />Geriatric, Pediatric: The effects of age on the pharmacokinetics of topical alprostadil<br />have not been studied. The Vitaros is not indicated for use in children or in individuals<br />below 18 years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Alprostadil, DDAIP and Vitaros (including DDAIP) have not shown genotoxic potential.<br />Carcinogenicity studies with alprostadil or Vitaros have not been conducted.<br />Carcinogenicity assessments of the excipient, DDAIP, found no tumor formation with<br />topical administration to mice and subcutaneously in rats. In the Tg.AC transgenic mouse<br />model administration of DDAIP at a concentration of 1.0% and 2.5% induced papillomas<br />in females and males respectively. This effect is not likely to be relevant for humans, as it<br />likely caused by irritation.<br />Alprostadil has no effect on sperm count or morphology. However, the excipient DDAIP<br />caused atrophy of the seminiferous tubules of the testes in rabbits when administered<br />locally at a concentration of 5%. A direct spermatotoxic effect of DDAIP could not be<br />tested, and the relevance for a possible reduced male fertility in humans is therefore<br />unknown. DDAIP administered subcutaneously to rats had no effect on fertility.<br />Alprostadil has been shown to be embryotoxic (decreased foetal weight) when<br />administered as a subcutaneous bolus to pregnant rats at low doses Higher doses resulted<br />in increased resorptions, reduced numbers of live foetuses, increased incidences of<br />visceral and skeletal variation and malformations, and maternal toxicity. Intravaginal<br />administration of PGE1 to pregnant rabbits resulted in no harm to the foetus.<br />Reproductive toxicity studies for DDAIP were performed after subcutaneous<br />administration to rats and rabbits. No effects were seen in rats, but in rabbits foetotoxicity<br />including increased malformations were seen at high doses, which was probably due to<br />maternal toxicity. No effects on post-natal; development were evident in rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Purified water<br />Ethanol, anhydrous<br />Ethyl laurate<br />Hydroxypropyl guar gum<br />Dodecyl-2-N, N-dimethylaminopropionate hydrochloride<br />Potassium dihydrogen phosphate<br />Sodium hydroxide, for pH adjustment<br />Phosphoric acid, for pH adjustment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                18 months
Once opened, use immediately, discard any unused portion.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C - 8&deg;C).<br />Do not freeze.<br />Unopened sachets may be kept out of the refrigerator by the patient, at a temperature<br />below 30 &deg;C for up to 3 days prior to use.<br />At the end of this period, the product should be discarded if not used.<br />Store in the original sachet in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vitaros is supplied in individual sachets containing one (1) AccuDose container. Each single<br />container contains 100 mg cream. Vitaros is available in unit cartons containing four<br />(4) containers and one (1) container. The sachets are composed of aluminium foil/laminate.<br />The container components are composed of polypropylene and polyethylene.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each container is for single use only.<br />Any unused medicinal product or waste material should be disposed of in accordance<br />with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Elis pharmaceuticals Ltd.
Vista Business Centre
50 Salisbury Road
Hounslow
Middlesex TW4 6JQ
United Kingdom
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                20/09/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>